NCT05536804: A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
- State
- Completed
- Phase
- Phase 2
- People
- 134 taking part
- Started
- 8 Feb 2023
- Primary completion
- 6 Jul 2026
- Arms
- Tirzepatide
- Results
- None posted
- 13 Sep 2022: Trial registered
- 8 Feb 2023: Trial started
- 30 Jul 2026: Trial completed